Europe’s Orphan Product Designations: 2015 3-Month Activity Rate
This Blog Post will compare the number of European Medicines Agency (EMA) COMP’s (Committee for Orphan Medicinal Products) positive opinions recommending Orphan Drug Designation (ODD), for the 1st Quarter 2014 versus the number of EMA COMP ODDs recommended for the 1st Quarter 2015.
|Month||# of 2014 EMA COMP ODDs **||# of 2015 EMA COMP ODDs ***||% Change From 2014 To 2015|
|Grand Totals||34||56||64.7 %|
Thus, there is an approximate increase of 65 % in the EMA COMP’s number of positive opinions recommending ODDs between the 1st Q 2014 and the 1st Q 2015.
** “# of 2014 EMA COMP ODDs” Column Link = Is the EMA COMP 2014 Meeting Report
*** “# of 2015 EMA COMP ODDs” Column Link = Is the EMA COMP 2015 Meeting Report.
Please Note: “Erlenmeyer Flasks” From Argonne US National Lab [Public domain in the US] | Wikimedia Commons.